In the revised WHO classification of CNS tumors of 2016, supratentorial ependymomas with C11orf95–RELA fusions were introduced as a novel specific tumor entity [31], initiating the era of a genetically based ependymoma classification. The gene discussed is RELA; the disease is ependymoma.